Pay Attention to EXEL - 未名空间MITBBS历史存档

国际科技财经博客移民网络热点娱乐民生时事公众号

Redian新闻

>未名空间

>Stock

Pay Attention to EXEL

Pay Attention to EXEL# Stock

c*r2014-07-24 07:07

1 楼

EXEL:
The company has the best line up of MAPK pathway inhibitors
Its pipeline is very complementary to ROCHE's, is a speculated target for
ROCHE.
Its MEK inhibitor cobimetinib is the best in class, and has shown good
results in combination with ROCHE's RAF inhibitor and PI3K inhibitor
Its market cap is only 700 million, a bargain for a biotech with a drug
already approved to market
etc etc.

c*r2014-07-24 07:07

2 楼

I call it again: pay attention to this stock.

c*r2014-07-24 07:07

3 楼

Call it 3 times and let it be.

r*r2014-07-24 07:07

4 楼

赞LZ马前炮！！

c*r2014-07-24 07:07

5 楼

YELP is in trouble. Run before ER (July 30th).

b*d2014-07-24 07:07

6 楼

Why is that?

【在 c********r 的大作中提到】

: YELP is in trouble. Run before ER (July 30th).

r*l2014-07-24 07:07

7 楼

I own it for a long time and am happy to see the recently rally.
But it is still very risky of the ER. Hope M.M.M. will bring some good news.

【在 c********r 的大作中提到】

: Call it 3 times and let it be.

c*r2014-07-24 07:07

8 楼

The small biz are fed up with yelp.

【在 b*d 的大作中提到】

: Why is that?

f*e2014-07-24 07:07

9 楼

when to buy exel？

EXEL:The company has the best line up of MAPK pathway inhibitorsIts pipeline
is very com........

【在 c********r 的大作中提到】

:
: The small biz are fed up with yelp.

x*e2014-07-24 07:07

10 楼

when to buy @ what price

【在 c********r 的大作中提到】

: EXEL:
: The company has the best line up of MAPK pathway inhibitors
: Its pipeline is very complementary to ROCHE's, is a speculated target for
: ROCHE.
: Its MEK inhibitor cobimetinib is the best in class, and has shown good
: results in combination with ROCHE's RAF inhibitor and PI3K inhibitor
: Its market cap is only 700 million, a bargain for a biotech with a drug
: already approved to market
: etc etc.

m*r2014-07-24 07:07

11 楼

I'm with you on this one - I bought lots shares 2 weeks ago..

c*r2014-07-24 07:07

12 楼

Anyone still holding EXEL? Now the market cap is near $3 billion.

m*n2014-07-24 07:07

13 楼

非常牛比
楼主现在还有什么推荐的吗

【在 c********r 的大作中提到】

: Anyone still holding EXEL? Now the market cap is near $3 billion.

c*r2014-07-24 07:07

14 楼

EKSO also has huge up potential.

G*s2014-07-24 07:07

15 楼

I bought this when it was $1.90, then added shares this year at $4.50, sold
all recently at $11.60. There maybe more upside for this one given there are
a lot of shorts, but I got my target and just need to cash in.

m*r2014-07-24 07:07

16 楼

sold
are
厉害啊。赞。给个pick？

【在 G*******s 的大作中提到】

: I bought this when it was $1.90, then added shares this year at $4.50, sold
: all recently at $11.60. There maybe more upside for this one given there are
: a lot of shorts, but I got my target and just need to cash in.

G*s2014-07-24 07:07

17 楼

That is the only sold stock during last year. Currently still holding NVDA
and DATA. May want to sell soon given the market failed to get into new high
ground.

m*r2014-07-24 07:07

18 楼

high
bro, give us some more thoughts on your trading ba. you got into EXEL after
a big gap down (normally I don't want to touch a stock if it has a recent
big gap down), why you entered the trade around 1.9 ar?
and you hold through the correction from 5.5$ to 3.6$, this correction
pretty big and long, how you were able to hold through it ar? particularly
EXEL is a bio and bio normally kind of hard to foretell ar.
and you added more after the big correction, sometimes this is hard for me
too. what triggered your action ar?
your NVDA is great ar, not sure about DATA, probably you also entered after
the big down. tell us some more on how you pick and hold stock ba.

【在 G*******s 的大作中提到】

: That is the only sold stock during last year. Currently still holding NVDA
: and DATA. May want to sell soon given the market failed to get into new high
: ground.

m*r2014-07-24 07:07

19 楼

very volatile ar. what's the story behind it?

【在 c********r 的大作中提到】

: EKSO also has huge up potential.

G*s2014-07-24 07:07

20 楼

I did FA on EXEL and know the odds was quite favorable even when it was
below 2. I should have sold some above 6 during the time. Earlier this year,
it was releasing good news after good news but the price was stagnant. I
added at $4.5 just before it took off. My target was $11.5 and sold once it
broke through. Maybe I should have yelled here after this one got above 7.
My experience was to keep quiet and then you earn. If you shout out then it
will fail.

G*s2014-07-24 07:07

21 楼

Currently I am watching at fertilizer group POT/CF/TNH. Not good time to get
in yet.

G*s2014-07-24 07:07

22 楼

NVDA is one that every break out type trader should jump on. Institution is
very much on it making it a very low risk play. Still it exceeded my
expectation.
I got in DATA when it was in 40s, just I know that they have a very good
product that is also well priced. A little bit risky on this one.

G*s2014-07-24 07:07

23 楼

So it depends, for you maybe it is easier to play when it breaks $7 and you
get very nice return in a short period. Long term holding needs guts and at
least some study one the stock.
I played NVDA based on TA instead of FA. I don't know and may not even care
why it was popped up after ER with huge volume. All I need to know is that
big fish are all in.

m*r2014-07-24 07:07

24 楼

year,
it
it
I see, so EXEL mainly is a FA play.
well, I think should yell when it's under two. :) but, that probably will
hurt you, as people might suspect you are pumping junks. :)

【在 G*******s 的大作中提到】

: I did FA on EXEL and know the odds was quite favorable even when it was
: below 2. I should have sold some above 6 during the time. Earlier this year,
: it was releasing good news after good news but the price was stagnant. I
: added at $4.5 just before it took off. My target was $11.5 and sold once it
: broke through. Maybe I should have yelled here after this one got above 7.
: My experience was to keep quiet and then you earn. If you shout out then it
: will fail.

m*r2014-07-24 07:07

25 楼

get
nice. thanks for sharing.
TNH seems getting ripe ar.
can you share some secrets on how to judge it's good time or not?

【在 G*******s 的大作中提到】

: Currently I am watching at fertilizer group POT/CF/TNH. Not good time to get
: in yet.

m*r2014-07-24 07:07

26 楼

is
en, NVDA I missed, very bad.
ok, so DATA seems also a FA play, DATA has some pretty 'scary' down days
after you entered, but you held on, nice ar...sometimes, those sudden sharp
down days would shake me out.

【在 G*******s 的大作中提到】

: NVDA is one that every break out type trader should jump on. Institution is
: very much on it making it a very low risk play. Still it exceeded my
: expectation.
: I got in DATA when it was in 40s, just I know that they have a very good
: product that is also well priced. A little bit risky on this one.

m*r2014-07-24 07:07

27 楼

you
at
care
ok,short term quick play is good, but I truly want is the under 2$ to 11$
play. I am now heavily towards FA play, almost every day I'd study companies
till mid-night. and I am trying to improve my guts to hold on.
For NVDA, how do you know big fish are all in ar?

【在 G*******s 的大作中提到】

: So it depends, for you maybe it is easier to play when it breaks $7 and you
: get very nice return in a short period. Long term holding needs guts and at
: least some study one the stock.
: I played NVDA based on TA instead of FA. I don't know and may not even care
: why it was popped up after ER with huge volume. All I need to know is that
: big fish are all in.

c*r2014-07-24 07:07

28 楼

It is over $13 now

【在 c********r 的大作中提到】

: EKSO also has huge up potential.

G*s2014-07-24 07:07

29 楼

This EU approval news is the last expected news. I was thinking about
holding it through its release but think MMs could sell on the news. So far
the chart is very strong so don't need to get off now. Let your profit run.

m*r2014-07-24 07:07

30 楼

far
nice, cong.

【在 G*******s 的大作中提到】

: This EU approval news is the last expected news. I was thinking about
: holding it through its release but think MMs could sell on the news. So far
: the chart is very strong so don't need to get off now. Let your profit run.

c*r2014-07-24 07:07

31 楼

Now $15

G*s2014-07-24 07:07

32 楼

走得太强啦，跟Ipsen合约里面有不少的milestone payment, 所以后面只要有消息放出
来就会涨，还有他们在日本的权利也会找合作者，他们只负责北美的销售
以前一直不涨有一个原因就是他们的那个贷款合同里面有stock conversion option,
自从他们把那个贷款还了之后阻力基本消失了，基本上就是使劲涨
我在$13附近又拿回来一点点（比起原来的少多了），真是不太会卖这种股票

【在 c********r 的大作中提到】

: Now $15

m*r2014-07-24 07:07

33 楼

大牛们威武。cong。

G*s2014-07-24 07:07

34 楼

Missed your question. That is what you look in the volume. Look historically
what is the average volume on ER　day and compare. If it is at least twice
the average of last four ER day volume, there is a good probability that big
fishes are in.
Example: When FB jumped from 29 to 37 after that ER showed them blossoming
in mobile advertising, the volume was huge and that is the sign that you can
ride the wave. How much you earn after that is up to you then.

companies

【在 m****r 的大作中提到】

: 大牛们威武。cong。

m*r2014-07-24 07:07

35 楼

historically
twice
big
can
wow, this is great information! thanks a lot for sharing the secrets. :)

【在 G*******s 的大作中提到】

: Missed your question. That is what you look in the volume. Look historically
: what is the average volume on ER　day and compare. If it is at least twice
: the average of last four ER day volume, there is a good probability that big
: fishes are in.
: Example: When FB jumped from 29 to 37 after that ER showed them blossoming
: in mobile advertising, the volume was huge and that is the sign that you can
: ride the wave. How much you earn after that is up to you then.
:
: companies

G*s2014-07-24 07:07

36 楼

Got shaken out today. Everyone on the ship be careful, this is still a bio
stock with very few revenue and lose money. Any set back will be punished
hard.

m*r2014-07-24 07:07

37 楼

looks like been shaken out is good ar. :)
bio is always so crazy, I just lack of nerve to play.

【在 G*******s 的大作中提到】

: Got shaken out today. Everyone on the ship be careful, this is still a bio
: stock with very few revenue and lose money. Any set back will be punished
: hard.